Sural nerve pathology in diabetic patients with minimal but progressive neuropathy

被引:240
作者
Malik, RA
Tesfaye, S
Newrick, PG
Walker, D
Rajbhandari, SM
Siddique, I
Sharma, AK
Boulton, AJM
King, RHM
Thomas, PK
Ward, JD
机构
[1] Manchester Royal Infirm, Dept Med, Manchester M13 9WL, Lancs, England
[2] Royal Hallamshire Hosp, Diabet Unit, Sheffield S10 2JF, S Yorkshire, England
[3] UCL Royal Free & Univ Coll, Sch Med, Dept Clin Neurosci, London, England
关键词
demyelination; diabetes; microangiopathy; nerve fibres; neuropathy; Schwann cell;
D O I
10.1007/s00125-004-1663-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis: The early pathological features of human diabetic neuropathy are not clearly defined. Therefore we quantified nerve fibre and microvascular pathology in sural nerve biopsies from diabetic patients with minimal neuropathy. Methods: Twelve diabetic patients underwent detailed assessment of neuropathy and fascicular sural nerve biopsy at baseline, with repeat assessment of neuropathy 8.7 +/- 0.6 years later. Results: At baseline, neuropathic symptoms, neurological deficits, quantitative sensory testing, cardiac autonomic function and peripheral nerve electrophysiology showed minimal abnormality, which deteriorated at follow-up. Myelinated fibre density, fibre and axonal area, and g-ratio were normal but teased fibre studies showed paranodal abnormalities (p < 0.001), segmental demyelination (p < 0.01) and remyelination (p < 0.01) without axonal degeneration. Unassociated Schwann cell profile density (p < 0.04) and unmyelinated axon density (p < 0.001) were increased and axon diameter was decreased (p < 0.007). Endoneurial capillaries demonstrated basement membrane thickening (p < 0.006), endothelial cell hyperplasia (p < 0.004) and a reduction in luminal area (p < 0.007). Conclusions/interpretation: The early pathological features of human diabetic neuropathy include an abnormality of the myelinated fibre Schwann cell and unmyelinated fibre degeneration with regeneration. These changes are accompanied by a significant endoneurial microangiopathy.
引用
收藏
页码:578 / 585
页数:8
相关论文
共 40 条
[1]   The North-West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community-based patient cohort [J].
Abbott, CA ;
Carrington, AL ;
Ashe, H ;
Bath, S ;
Every, LC ;
Griffiths, J ;
Hann, AW ;
Hussein, A ;
Jackson, N ;
Johnson, KE ;
Ryder, CH ;
Torkington, R ;
Van Ross, ERE ;
Whalley, AM ;
Widdows, P ;
Williamson, S ;
Boulton, AJM .
DIABETIC MEDICINE, 2002, 19 (05) :377-384
[3]  
Arezzo JC, 2002, INT REV NEUROBIOL, V50, P229
[4]   Diabetic somatic neuropathies [J].
Boulton, AJM ;
Malik, RA ;
Arezzo, JC ;
Sosenko, JM .
DIABETES CARE, 2004, 27 (06) :1458-1486
[5]   MORPHOMETRY OF ENDONEURIAL CAPILLARIES IN DIABETIC SENSORY AND AUTONOMIC NEUROPATHY [J].
BRADLEY, J ;
THOMAS, PK ;
KING, RHM ;
LLEWELYN, JG ;
MUDDLE, JR ;
WATKINS, PJ .
DIABETOLOGIA, 1990, 33 (10) :611-618
[6]   RELATIONSHIP OF ENDONEURIAL CAPILLARY ABNORMALITIES TO TYPE AND SEVERITY OF DIABETIC POLYNEUROPATHY [J].
BRITLAND, ST ;
YOUNG, RJ ;
SHARMA, AK ;
CLARKE, BF .
DIABETES, 1990, 39 (08) :909-913
[7]   ASSOCIATION OF PAINFUL AND PAINLESS DIABETIC POLYNEUROPATHY WITH DIFFERENT PATTERNS OF NERVE-FIBER DEGENERATION AND REGENERATION [J].
BRITLAND, ST ;
YOUNG, RJ ;
SHARMA, AK ;
CLARKE, BF .
DIABETES, 1990, 39 (08) :898-908
[8]   Effects of the protein kinase Cβ inhibitor LY333531 on neural and vascular function in rats with streptozotocin-induced diabetes [J].
Cotter, MA ;
Jack, AM ;
Cameron, NE .
CLINICAL SCIENCE, 2002, 103 (03) :311-321
[9]   NERVE GLUCOSE, FRUCTOSE, SORBITOL, MYOINOSITOL, AND FIBER DEGENERATION AND REGENERATION IN DIABETIC NEUROPATHY [J].
DYCK, PJ ;
ZIMMERMAN, BR ;
VILEN, TH ;
MINNERATH, SR ;
KARNES, JL ;
YAO, JK ;
PODUSLO, JF .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (09) :542-548
[10]   Risk factors for severity of diabetic polyneuropathy - Intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort [J].
Dyck, PJ ;
Davies, JL ;
Wilson, DM ;
Service, FJ ;
Melton, LJ ;
O'Brien, PC .
DIABETES CARE, 1999, 22 (09) :1479-1486